Design of a Double-Blind, Placebo-Controlled, Phase-Iii Trial in Patients with Parkinson's Disease and End-Of-Dose Motor Fluctuations: Opicapone Superiority Vs. Placebo
AuthID
P-002-5WD
P-002-5WD
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service